The COVID-19 vaccine is a critical pandemic control tool, alongside testing and prevention. It is possible to avoid death from SARS COV-2, serious sickness, and COVID-19 with vaccination.
The National Immunization Plan is followed when administering the COVID-19 vaccine in Moldova.
In March, the COVAX platform delivered 14,400 doses of COVID-19 vaccination to the Republic of Moldova. Moldova was the first European country to get COVID-19 vaccines from COVAX.
There will be an equitable distribution of COVID-19 vaccines worldwide as a result of this historic delivery.
Vaccines for COVID-19 are a top priority for COVAX, which aims to reduce the time it takes to develop and produce them while also making them available to 20 percent of the population in 92 countries. GAVI, WHO, and CIAP operate COVAX (CEPI).
Pfizer, Janssen and Sinovac and Sinopharm vaccines are accessible in Moldova. Vaccines are available at no cost to the general public from a family doctor or vaccination center.
At that time, 25.84 percent of the country had received a single dosage and 24.84 percent had received a full program, totaling 1,508,479 doses. 91.02 percent and 90 percent, respectively, of medical personnel have received the full series of vaccinations.
An official from the Municipal Clinical Hospital for Children with Infectious Diseases was the first person to receive an injection.
As of 2021, Moldova will get 24,570 BioNTech-Pfizer vaccine doses and up to 264,000 AstraZeneca vaccine doses through the COVAX mechanism. Representative of UNICEF Maha Damaj: What’s the matter?
There is a COVID-19 vaccine information panel published by UNICEF. The COVID-19 vaccination market and the COVAX Facility’s efforts to ensure fair and equitable access for every country may be tracked using this interactive tool, which can be used by nations, partners, and industry representatives.